Vivimed Labs is currently trading at Rs. 15.80, up by 0.70 points or 4.64% from its previous closing of Rs. 15.10 on the BSE.
The scrip opened at Rs. 15.80 and has touched a high and low of Rs. 17.00 and Rs. 15.80 respectively.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 66.35 on 07-Sep-2018 and a 52 week low of Rs. 11.20 on 23-Jul-2019.
Last one week high and low of the scrip stood at Rs. 17.00 and Rs. 14.65 respectively. The current market cap of the company is Rs. 125.20 crore.
The promoters holding in the company stood at 34.23%, while Institutions and Non-Institutions held 4.70% and 60.95% respectively.
Vivimed Labs has entered into definitive agreements for transfer and sale of its wholly owned subsidiary– Vivimed Labs Europe to Vivimed Specialty Chemicals UK (buyer) which forms part of the Speciality Chemical business of the company, pursuant to the shareholders resolutions passed through postal ballot notice dated on August 23, 2018.The transaction is supported by foreign institutional investor on behalf of buyer.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.